1) Russo I, Miotto S, Colpo A, et al:Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Int Wound J 2017;13:282-4 2) Ohno M, Koyama S, Ohara M, et al:Pyoderma gangrenosum with ulcerative colitis successfully treated by the combination of granulocyte and monocyte adsorption apheresis and corticosteroids. Intern Med 2016;55:25-30 3) Ikeda K, Hamada T, Otsuka M, Iwatsuki K:Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis. Eur J Dermatol 2011;21:804-5 4) Hanafusa T, Azukizawa H, Umegaki N, et al:Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease. J Dermatol 2011;38:507-10 5) Kawakami T, Yamazaki M, Soma Y:Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis. Am J Gastroenterol 2009;104:2363-4 6) Okuma K, Mitsuishi K, Hasegawa T, et al:A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis. Ther Apher Dial 2007;11:387-90 7) Seishima M, Mizutani Y, Shibuya Y, et al:Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum. Ther Apher Dial 2007;11:177-82 8) Kanekura T, Kawahara K, Maruyama I, Kanzaki T:Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Ther Apher Dial 2005;9:292-6 9) Kanekura T, Maruyama I, Kanzaki T:Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 2002;47:320-1
